CAS 120202-66-6
:Clopidogrel hydrogen sulfate
Description:
Clopidogrel hydrogen sulfate is a pharmaceutical compound primarily used as an antiplatelet agent to prevent blood clots in patients at risk of cardiovascular events. It is a prodrug that requires metabolic activation in the liver to exert its therapeutic effects. The substance is characterized by its ability to irreversibly inhibit the P2Y12 receptor on platelets, thereby reducing platelet aggregation. Clopidogrel hydrogen sulfate is typically administered orally and is known for its relatively high bioavailability and long half-life, allowing for once-daily dosing. The compound is soluble in water and exhibits stability under normal storage conditions, although it should be protected from light and moisture. Common side effects may include bleeding complications, gastrointestinal disturbances, and hypersensitivity reactions. Due to its mechanism of action, it is often prescribed in conjunction with other antiplatelet or anticoagulant therapies, particularly in patients with a history of myocardial infarction or stroke. Monitoring for efficacy and adverse effects is essential during treatment.
Formula:C15H16ClNO6S2
InChI:InChI=1/C15H14ClNO2S.H2O4S/c16-12-4-2-1-3-11(12)14(15(18)19)17-7-5-13-10(9-17)6-8-20-13;1-5(2,3)4/h1-4,6,8,14H,5,7,9H2,(H,18,19);(H2,1,2,3,4)/t14-;/m0./s1
InChI key:InChIKey=FDEODCTUSIWGLK-RSAXXLAASA-N
SMILES:[C@H](C(OC)=O)(N1CC2=C(CC1)SC=C2)C3=C(Cl)C=CC=C3.S(=O)(=O)(O)O
Synonyms:- (+)-(S)-5-[(2-Chlorophenyl)(methoxycarbonyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]-pyridin-5-ium hydrogen sulfate]
- (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoic acid sulfate (1:1)
- (S)-(+)-Clopidogrel hydrogen sulfate
- (S)-(+)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate bisulfate
- (S)-(+)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate
- Areplex
- Clopidix
- Clopidogerl Bisulfate
- Clopidogrel Bisulfate
- Clopidogrel Bisulfate I
- Clopidogrel Bisulfate II
- Clopidogrel Bisulfate, FormI/FormII
- Clopidogrel Hydrogen Sulphate
- Clopidogrel Hydrogensulfate
- Clopidogrel Sulphate
- Clopidogrel bisulphate
- Clopidogrel bisulphate Ⅰ/Ⅱ
- Clopidogrel hemisulfate
- Clopidogrel sulfate
- Iscover
- Methyl (+)-(S)-A-(2-Chlorophenyl)-6,7-Dihydrothieno[3,2-C]Pyridine-5(4H)Acetate, Hydrogen Sulfate Salt
- Methyl (S)-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)(2-chlorophenyl)ethanoate hydrogen sulfate
- Myogrel
- Plavitor
- Plavix
- Sr 25990C
- Stroka
- Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (S)-, sulfate (1:1)
- Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αS)-, sulfate (1:1)
- Trombex
- Zyllt
- Clopidogrel hydrogen sulfate
- (S)-alpha-(2-Chlorophenyl)-6,7-dihydrothieno[3.2-c]pyridine-5(4H)-aceticacidmethylesterhydrogensulfate
- Clopidogrelhydrogenesulfate
- Clopidogrel (Hydrogen)
- (2-Chlorophenyl)-6,7–dihydrothieno[3,2-C]pyridine-5-(4H)-acetic acid methyl ester sulfate
- d-Clopidogrel
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 17 products.
(S)-(+)-Clopidogrel Sulfate
CAS:Formula:C16H16ClNO2S·H2SO4Purity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:419.89Clopidogrel hydrogen sulfate
CAS:Clopidogrel hydrogen sulfateFormula:C16H18ClNO6S2Purity:99.4%Color and Shape:Off-WhiteMolecular weight:419.02641CLOPIDOGREL HYDROGEN SULFATE CRS
CAS:CLOPIDOGREL HYDROGEN SULFATE CRSFormula:C16H18ClNO6S2Color and Shape:White. Whitish. Powder.Molecular weight:419.9002Clopidogrel Bisulfate
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO2S·H2SO4Color and Shape:White Off-White PowderMolecular weight:321.05903Thieno[3,2-c]pyridine-5(4H)-acetic acid,a-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (aS)-, sulfate (1:1)
CAS:Formula:C16H18ClNO6S2Purity:98%Color and Shape:SolidMolecular weight:419.9002Clopidogrel hydrogen sulfate
CAS:<p>Clopidogrel hydrogen sulfate is a selective P2Y12 receptor blocker that inhibits platelet adhesion and aggregation.</p>Formula:C16H16ClNO2S·H2SO4Purity:99.57% - 99.79%Color and Shape:SolidMolecular weight:419.9Clopidogrel Sulfate
CAS:Formula:C16H16ClNO2S·H2SO4Color and Shape:White To Off-White SolidMolecular weight:321.82 98.07(S)-(+)-Clopidogrel hydrogen sulfate
CAS:Formula:C16H16ClNO2S·H2SO4Purity:≥ 98.0%Color and Shape:White to off-white powderMolecular weight:419.90S-(+)-Clopidogrel Hydrogen Sulfate
CAS:<p>Applications Used as an antithrombotic.<br>References Mills, D.C.B., et al.: Arterioscler. Thromb., 12, 430 (1992), Feuerstein, G., et al.: Exp. Opin. Invest. Drugs, 4, 425 (1995)<br></p>Formula:C16H16ClNO2S·H2O4SColor and Shape:Off-WhiteMolecular weight:419.90S-(+)-Clopidogrel hydrogen sulfate
CAS:<p>Clopidogrel is a potent inhibitor of the platelet aggregation. It reduces blood clotting by inhibiting the ADP receptor on the surface of platelets, thereby inhibiting the aggregation and adhesion of platelets. Clopidogrel has been shown to be effective in preventing thrombosis, myocardial infarction (heart attack), and stroke. Clopidogrel inhibits the activity of cytochrome P450 3A4 (CYP3A4) and p2Y 12 receptors. Clopidogrel has been shown to have synergic effects with nonsteroidal anti-inflammatory drugs (NSAIDs). The polymorphic nature of Clopidogrel can be monitored using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification in biological samples such as human serum and plasma.</p>Formula:C16H18ClNO6S2Purity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:419.9 g/molS-(+)-Clopidogrel hydrogen sulfate - Bio-X ™
CAS:<p>Clopidogrel is a potent inhibitor of the platelet aggregation. It reduces blood clotting by inhibiting the ADP receptor on the surface of platelets, thereby inhibiting the aggregation and adhesion of platelets. Clopidogrel has been shown to be effective in preventing thrombosis, myocardial infarction (heart attack), and stroke. Clopidogrel inhibits the activity of cytochrome P450 3A4 (CYP3A4) and p2Y 12 receptors. Clopidogrel has been shown to have synergic effects with nonsteroidal anti-inflammatory drugs (NSAIDs). The polymorphic nature of Clopidogrel can be monitored using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification in biological samples such as human serum and plasma.</p>Formula:C16H16ClNO2S•H2SO4Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:419.9 g/mol
![Thieno[3,2-c]pyridine-5(4H)-acetic acid,a-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (aS)-, sulf…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA00ILNY.jpg&w=3840&q=75)
